Total Payments
$42,525
2024 Payments
$23,822
Companies
34
Transactions
231
Medicare Patients
56
Medicare Billing
$3,056
Payment Breakdown by Category
Other$16,128 (37.9%)
Travel$11,294 (26.6%)
Food & Beverage$8,887 (20.9%)
Consulting$6,217 (14.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $11,294 | 26 | 26.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,345 | 8 | 24.3% |
| Food and Beverage | $8,887 | 184 | 20.9% |
| Consulting Fee | $6,217 | 9 | 14.6% |
| Honoraria | $5,783 | 4 | 13.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | $13,379 | 49 | $0 (2024) |
| Evoke Pharma, Inc. | $11,224 | 13 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $6,293 | 33 | $0 (2024) |
| Ardelyx, Inc. | $5,695 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,449 | 9 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $937.34 | 15 | $0 (2024) |
| Lilly USA, LLC | $431.37 | 12 | $0 (2024) |
| Mahana Therapeutics, Inc. | $405.00 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $371.76 | 15 | $0 (2024) |
| Celgene Corporation | $332.91 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,822 | 118 | Phathom Pharmaceuticals, Inc. ($13,379) |
| 2023 | $7,445 | 45 | Evoke Pharma, Inc. ($4,470) |
| 2022 | $7,160 | 34 | Evoke Pharma, Inc. ($4,480) |
| 2021 | $4,098 | 34 | EVOKE PHARMA, INC. ($2,274) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $717.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $369.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $59.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $52.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Phathom Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $1,184.60 | General |
| 12/06/2024 | Phathom Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $417.95 | General |
| 12/06/2024 | Phathom Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $203.49 | General |
| 12/06/2024 | Phathom Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $140.67 | General |
| 12/06/2024 | Phathom Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $81.59 | General |
| 12/06/2024 | Phathom Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $71.31 | General |
| 12/06/2024 | Phathom Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $55.21 | General |
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Honoraria | Cash or cash equivalent | $717.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $123.74 | General |
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $37.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $120.02 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $820.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 11 | 15 | $2,180 | $583.98 |
| 2021 | 2 | 32 | 44 | $7,192 | $2,019 |
| 2020 | 1 | 13 | 17 | $2,410 | $453.77 |
Total Patients
56
Total Services
76
Medicare Billing
$3,056
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 15 | $2,180 | $583.98 | 26.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 20 | 32 | $4,590 | $1,428 | 31.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 12 | 12 | $2,602 | $590.39 | 22.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 13 | 17 | $2,410 | $453.77 | 18.8% |
About Tedra Gray, N.P
Tedra Gray, N.P is a Acute Care healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659358760.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tedra Gray, N.P has received a total of $42,525 in payments from pharmaceutical and medical device companies, with $23,822 received in 2024. These payments were reported across 231 transactions from 34 companies. The most common payment nature is "Travel and Lodging" ($11,294).
As a Medicare-enrolled provider, Gray has provided services to 56 Medicare beneficiaries, totaling 76 services with total Medicare billing of $3,056. Data is available for 3 years (2020–2022), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location Chicago, IL
- Active Since 12/29/2005
- Last Updated 04/26/2016
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1659358760
Products in Payments
- GIMOTI (Drug) $11,224
- VOQUEZNA (Drug) $11,100
- RELISTOR (Drug) $3,246
- XIFAXAN (Drug) $1,623
- DUPIXENT (Biological) $1,328
- ENTYVIO (Biological) $602.17
- STELARA (Biological) $319.24
- OMVOH (Drug) $318.42
- ZEPOSIA (Drug) $310.36
- TRULANCE (Drug) $211.87
- IBSRELA (Drug) $194.51
- RINVOQ (Biological) $147.38
- JAKAFI (Drug) $139.61
- GATTEX (Drug) $104.49
- VERZENIO (Drug) $99.64
- KEYTRUDA (Biological) $98.28
- TAGRISSO (Drug) $89.54
- Epclusa (Drug) $81.24
- TUKYSA (Drug) $81.00
- Kadcyla (Biological) $58.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Chicago
Gwen Cassidy, Apn, APN
Acute Care — Payments: $46,167
Acute Care $46,167
Erin Darguzas, Apn, APN
Acute Care — Payments: $17,131
Acute Care $17,131
Mrs. Katie Meador, Nurse Practitioner, NURSE PRACTITIONER
Acute Care — Payments: $15,088
Acute Care $15,088
Sarah Miyata, Np, NP
Acute Care — Payments: $11,047
Acute Care $11,047
Viktoriya Kagan, Aprn, Cnp, APRN, CNP
Acute Care — Payments: $7,096
Acute Care $7,096
Danielle Zielinski, Acnp, ACNP
Acute Care — Payments: $5,292
Acute Care $5,292